A Study of LY4515100 in Healthy Participants
Phase 1
40
about 6 months
18–65
1 site in TX
About this study
This trial is testing the safety and how well LY4515100 is tolerated when given to healthy people. Blood tests will be done to see how the body processes the drug and its effects on the body. The study will last up to 30 days and include six overnight stays.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take LY4515100 via MAD
- 2.Take LY4515100 via SAD
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Number of participants with one or more serious adverse event(s) (SAEs) of LY4515100
Secondary: PK: Maximum Observed Drug Concentration (Cmax) of LY4515100, PK: Time of maximum observed drug concentration (tmax) of LY4515100, Pharmacokinetics (PK): Area Under the Concentration versus Time Curve (AUC) of LY4515100